logo

Antibacterial Nanoparticles Therapeutic (Ant) Study

Sector: Aerospace & Defense • Location: Silver Spring, Maryland, United States of America

Source: SAM.gov

Tender
Special Notice

The University of Notre Dame will conduct a study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. There is a need to bring novel therapeutics to the mili

Status
Closed
Sector
Aerospace & Defense, Hospital, Government, Education, Commercial, Residential
Location
Silver Spring, Maryland, United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about Antibacterial Nanoparticles Therapeutic (Ant) Study

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Antibacterial Nanoparticles Therapeutic (Ant) Study” is a tender record in Taiyo, linked to the Aerospace & Defense sector. It is issued for works, goods, or services related to Silver Spring, Maryland, United States of America.

Participants

Not available for this record.

Status

Original status

special notice

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

The University of Notre Dame will conduct a study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. There is a need to bring novel therapeutics to the military health care to treat MDR P. aeruginosa. The collaborative partner of this study is the University of Notre Dame, the patent owner of a unique technology (phage-mimicking nanoparticles) that provides life-saving therapeutics for service members and civilians. This technology was awarded a patent in 2024 - US-12161725-B2. Government anticipates that the collaborative efforts will contribute to Food and Drug Administration (FDA) approval of this innovative therapy, leading to reduced morbidity and mortality rates, enhanced operational readiness, advanced combat medicine, and substantial contributions to broader biosecurity initiatives and civilian health improvements.

Original sector

Professional, Scientific, and Technical Services

Location

Country

United States of America (USA)

State

Maryland

City

Silver Spring

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Aerospace & Defense, Hospital, Government, Education, Commercial, Residential

Article published date

2026-04-15

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender